Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study

Overview of attention for article published in Drug Safety, October 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 6 X users

facebook: 1 Facebook page

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 10,093 followers.

Routinely collected #HealthData can be analysed to support signal validation and prioritisation in #pharmacovigilance, as shown by UMC's Judith Brand and fellow UMC and @IMI_EHDEN colleagues in this #DrugSafety article. 📖 Dive into the article for more…

RT @prieto_alhambra: New paper out: “Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.